MedTrace Logo

Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation

NCT03103100 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-08-31

Study results available
· View outcomes & findings →

Summary

This study will compare and determine the most ideal local anesthetic (LA) solution to activate a labor epidural: lidocaine, bupivacaine, or a combination of bupivacaine plus lidocaine.

Conditions

  • Labor Pain

Interventions

DRUG

1% Lidocaine

10 mL of 1% lidocaine

DRUG

0.25% Bupivacaine

10 mL of 0.25% bupivacaine

DRUG

Bupivacaine plus Lidocaine

5 mL of 1% lidocaine and 5 mL of 0.25% bupivacaine

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Mark F Powell, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-08
Primary Completion
2019-07-01
Completion
2019-09-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103100 on ClinicalTrials.gov